Page last updated: 2024-08-16

tetrahydropalmatine and Breast Neoplasms

tetrahydropalmatine has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
He, J; Hu, T; Huang, H; Liao, Y; Liu, B; Liu, N; Liu, X; Shao, Z; Xia, X; Xu, Q; Yu, C	1

Other Studies

1 other study(ies) available for tetrahydropalmatine and Breast Neoplasms

Article	Year
Targeting ERα degradation by L-Tetrahydropalmatine provides a novel strategy for breast cancer treatment. International journal of biological sciences, 2020, Volume: 16, Issue:12 Topics: Antineoplastic Agents, Hormonal; Berberine Alkaloids; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Dopamine Antagonists; Drug Resistance, Neoplasm; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Models, Molecular; Protein Conformation; Tamoxifen	2020

Article

Year

Targeting ERα degradation by L-Tetrahydropalmatine provides a novel strategy for breast cancer treatment.

International journal of biological sciences, 2020, Volume: 16, Issue:12

Topics: Antineoplastic Agents, Hormonal; Berberine Alkaloids; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Dopamine Antagonists; Drug Resistance, Neoplasm; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Models, Molecular; Protein Conformation; Tamoxifen

2020